N-deacetylated BMS-202
N-deacetylated BMS-202 is the deacetylated of BMS-202. BMS-202 is an inhibitor of the PD-1/PD-L1 interaction, mainly used for cancer treatment.
Product Specifications
CAS Number
[2310135-18-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/N-deacetylated_BMS-202.html
Purity
98.03
Solubility
DMSO : ≥ 36 mg/mL
Smiles
NCCNCC1=CC=C(OCC2=C(C)C(C3=CC=CC=C3)=CC=C2)N=C1OC
Molecular Formula
C23H27N3O2
Molecular Weight
377.48
Precautions
H302, H315, H319, H335
References & Citations
[1]WO2015034820 A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034040-ML405 100 µL
CNGB3, NT (CNGB3, Cyclic nucleotide-gated cation channel beta-3, Cone photoreceptor cGMP-gated channel subunit beta, Cyclic nucleotide-gated cation channel modulatory subunit, Cyclic nucleotide-gated channel beta-3) (MaxLight 405) discontinued
Ask
View Details 